Skip to main content

Research Repository

Advanced Search

Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease

Cheow, HK; Voutnis, DD; Evans, JW; Szczepura, K; Swift, EA; Bird, NJ; Ruparelia, P; Solanki, CK; Ballinger, JR; Chilvers, ER; Middleton, SJ; Peters, AM

Authors

HK Cheow

DD Voutnis

JW Evans

EA Swift

NJ Bird

P Ruparelia

CK Solanki

JR Ballinger

ER Chilvers

SJ Middleton

AM Peters



Abstract

Purpose
Whole-body gamma camera counting is an alternative to faecal 111In collection for quantifying disease activity in inflammatory bowel disease (IBD) but requires administration of imaging activities of 111In. The aim of this study was to explore a dedicated whole-body counter which requires 20-fold less activity than gamma camera counting.

Methods
Thirty patients with known or suspected IBD received 99mTc-granulocytes (∼200 MBq) and 111In-granulocytes (∼0.5 MBq). The 99mTc-cells were injected 45 min after the 111In-cells and immediately after a baseline 111In whole-body count. The decay-corrected count at 120 h was expressed as a fraction of baseline to give whole-body 111In retention (WBR). One patient was excluded as the injected cells were non-viable.

Results
Median 45-min intravascular 111In recovery was 35% in patients compared with 43% in six normal volunteers (p<0.05). WBR in normals ranged from 91% to 93% and in 11 patients with negative 99mTc imaging from 87% to 96%. Only one of 11 patients with negative imaging had WBR <90% while 11/12 patients with WBR <90% had abnormal imaging. Ten of 13 patients with Crohn’s disease (CD) had abnormal imaging. The lowest WBR in these ten was 77% and six had values of >90%. There was a significant association between WBR and 99mTc image grade (Rs=0.73, p<0.002) in 16 patients without CD, but not in 13 patients with CD (Rs=0.54, p>0.05).

Conclusion
Dedicated whole-body counting is able to quantify disease activity in IBD but may give normal values in active CD.

Journal Article Type Article
Acceptance Date May 28, 2004
Online Publication Date Oct 29, 2004
Publication Date Mar 1, 2005
Deposit Date Feb 26, 2021
Journal European Journal of Nuclear Medicine and Molecular Imaging
Print ISSN 1619-7070
Electronic ISSN 1619-7089
Publisher Springer Verlag
Volume 32
Issue 3
Pages 329-337
DOI https://doi.org/10.1007/s00259-004-1617-7
Publisher URL https://doi.org/10.1007/s00259-004-1617-7
Related Public URLs http://link.springer.com/journal/259